UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 578

Sortiert nach

The origin of the excess transit absorption in the HD 189733 system: planet or star?

Monthly notices of the Royal Astronomical Society, 2016-10, Vol.462 (1), p.1012-1028

2016

Volltextzugriff (PDF)

A candidate super-Earth planet orbiting near the snow line of Barnard's star

Nature (London), 2018-11, Vol.563 (7731), p.365-368

2018

Volltextzugriff (PDF)

The effect of ISM absorption on stellar activity measurements and its relevance for exoplanet studies

Astronomy and astrophysics (Berlin), 2017-05, Vol.601, p.A104

2017

Volltextzugriff (PDF)

SALT observations of the chromospheric activity of transiting planet hosts: mass-loss and star–planet interactions

Monthly notices of the Royal Astronomical Society, 2017-04, Vol.466 (1), p.738-748

2017

Volltextzugriff (PDF)

DMPP-4: candidate sub-Neptune mass planets orbiting a naked-eye star

Monthly notices of the Royal Astronomical Society, 2023-07, Vol.524 (4), p.5196-5212

2023

Volltextzugriff (PDF)

Mental Health screening in cystic fibrosis centres across Europe

Journal of cystic fibrosis, 2019-03, Vol.18 (2), p.299-303

2019

Volltextzugriff (PDF)

WS12.3 End-of-life-issues – a single-center retrospective analysis

Journal of cystic fibrosis, 2017-06, Vol.16, p.S21-S22

2017

Volltextzugriff (PDF)

48 Real world experience with lumacaftor/ivacaftor

Journal of cystic fibrosis, 2017-06, Vol.16, p.S76-S76

2017

Volltextzugriff (PDF)

186 First experience with a new inhaled antibiotic treatment

Journal of cystic fibrosis, 2017-06, Vol.16, p.S114-S114

2017

Volltextzugriff (PDF)

Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patients

Journal of antimicrobial chemotherapy, 2016-03, Vol.71 (3), p.711-717

2016

Volltextzugriff (PDF)

The suppression of fluorescence peaks in energy-dispersive X-ray diffraction

Journal of applied crystallography, 2014-10, Vol.47 (5), p.1708-1715

2014

Volltextzugriff (PDF)

MRI of cystic fibrosis lung manifestations: sequence evaluation and clinical outcome analysis

Clinical radiology, 2017-09, Vol.72 (9), p.754-763

2017

Volltextzugriff (PDF)

102 Transmission of non-tuberculous mycobacteria in patients with cystic fibrosis

Journal of cystic fibrosis, 2016-06, Vol.15, p.S77-S77

2016

Volltextzugriff (PDF)

39 Results of a multicenter, open-label, phase IV study, to evaluate the early response to Bronchitol® in patients with cystic fibrosis

Journal of cystic fibrosis, 2016-06, Vol.15, p.S61-S61

2016

Volltextzugriff (PDF)

119 Cellular allergy tests for antibiotic drug hypersensitivity in cystic fibrosis

Journal of cystic fibrosis, 2015-06, Vol.14, p.S87-S87

2015

Volltextzugriff (PDF)

303 Kwashiorkor – a clinical manifestation of cystic fibrosis

Journal of cystic fibrosis, 2014-06, Vol.13, p.S126-S126

2014

Volltextzugriff (PDF)

167 Epidemiology and risk factors for CF arthropathy

Journal of cystic fibrosis, 2014-06, Vol.13, p.S89-S89

2014

Volltextzugriff (PDF)

WS14.3 Exercise testing as diagnostic marker for the outcome after intravenous antibiotic therapy for patients with cystic fibrosis

Journal of cystic fibrosis, 2015-06, Vol.14, p.S27-S27

2015

Volltextzugriff (PDF)

ePS02.5 A new risk factor predicts ABPA in patients with cystic fibrosis

Journal of cystic fibrosis, 2015-06, Vol.14, p.S45-S45

2015

Volltextzugriff (PDF)

160 Is pet ownership a risk for bacterial or fungal infections in patients with CF?

Journal of cystic fibrosis, 2013-06, Vol.12, p.S89-S89

2013

Volltextzugriff (PDF)

Measuring health-related quality of life in clinical trials in cystic fibrosis

Journal of cystic fibrosis, 2011-06, Vol.10, p.S82-S85

2011

Volltextzugriff (PDF)

146 Sinonasal inhalation of isotonic vs. hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis – results of a multicentre, double-blind, controlled prospective trial

Journal of cystic fibrosis, 2015-06, Vol.14, p.S95-S95

2015

Volltextzugriff (PDF)

WS10.6 Organ-specific CFTR dysfunction: Comparison of biomarkers for CF diagnosis and CFTR modulator effects

Journal of cystic fibrosis, 2013-06, Vol.12, p.S21-S21

2013

Volltextzugriff (PDF)

324 First experiences with a patient education program for children with cystic fibrosis and their parents

Journal of cystic fibrosis, 2013-06, Vol.12, p.S131-S131

2013

Volltextzugriff (PDF)

Association of the CLCA1 p.S357N Variant With Meconium Ileus in European Patients With Cystic Fibrosis

Journal of pediatric gastroenterology and nutrition, 2010-03, Vol.50 (3), p.347-349

2010

Volltextzugriff (PDF)

1 – 25 von 578

Suche als RSS-Feed

Aktive Filter

KollektionJstor Complete Legacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(483)
Mit Volltextzugriff
(517)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(353)
Life Sciences & Biomedicine
(180)
Humans
(170)
Technology
(144)
Computer Science
(130)
Computer Science, Theory & Methods
(110)
Female
(93)
Computer Science, Information Systems
(92)
Male
(90)
Adult
(67)
Biological And Medical Sciences
(62)
Medical Sciences
(57)
Physical Sciences
(43)
Middle Aged
(41)
Child
(36)
Computer Science, Artificial Intelligence
(33)
Adolescent
(31)
Aged
(28)
Exact Sciences And Technology
(27)
Pulmonary/respiratory
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The origin of the excess transit absorption in the HD 189733 system: planet or star?

A candidate super-Earth planet orbiting near the snow line of Barnard's star

The effect of ISM absorption on stellar activity measurements and its relevance for exoplanet studies

SALT observations of the chromospheric activity of transiting planet hosts: mass-loss and star–planet interactions

DMPP-4: candidate sub-Neptune mass planets orbiting a naked-eye star

Mental Health screening in cystic fibrosis centres across Europe

WS12.3 End-of-life-issues – a single-center retrospective analysis

48 Real world experience with lumacaftor/ivacaftor

186 First experience with a new inhaled antibiotic treatment

Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patients

The suppression of fluorescence peaks in energy-dispersive X-ray diffraction

MRI of cystic fibrosis lung manifestations: sequence evaluation and clinical outcome analysis

102 Transmission of non-tuberculous mycobacteria in patients with cystic fibrosis

39 Results of a multicenter, open-label, phase IV study, to evaluate the early response to Bronchitol® in patients with cystic fibrosis

119 Cellular allergy tests for antibiotic drug hypersensitivity in cystic fibrosis

303 Kwashiorkor – a clinical manifestation of cystic fibrosis

167 Epidemiology and risk factors for CF arthropathy

WS14.3 Exercise testing as diagnostic marker for the outcome after intravenous antibiotic therapy for patients with cystic fibrosis

ePS02.5 A new risk factor predicts ABPA in patients with cystic fibrosis

160 Is pet ownership a risk for bacterial or fungal infections in patients with CF?

Measuring health-related quality of life in clinical trials in cystic fibrosis

146 Sinonasal inhalation of isotonic vs. hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis – results of a multicentre, double-blind, controlled prospective trial

WS10.6 Organ-specific CFTR dysfunction: Comparison of biomarkers for CF diagnosis and CFTR modulator effects

324 First experiences with a patient education program for children with cystic fibrosis and their parents

Association of the CLCA1 p.S357N Variant With Meconium Ileus in European Patients With Cystic Fibrosis

Aktive Filter

Suchergebnisse filtern